Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$52M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$12.7M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$9.9M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$8.15M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$224M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$38.3M |
| 3 |
Honeywell
HON
|
+$12.9M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.71M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.87% |
| 2 | Miscellaneous | 30.19% |
| 3 | Technology | 8.1% |
| 4 | Financials | 3.93% |
| 5 | Communication Services | 2.83% |
Similar funds
Greenleaf Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Greenleaf Trust held 910 positions worth $10.4B, up 2.1% from $10.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Greenleaf Trust's Q2 2026 filing shows 106 new, 328 increased, 392 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 12,478 shares worth $2.37M. The largest sale was Stryker, an estimated $224M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 53% a quarter earlier, followed by Miscellaneous and Technology.
- Greenleaf Trust's largest Q2 2026 buy was AstraZeneca: 12,478 shares worth $2.37M.
- Greenleaf Trust added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $52M increase.
- Greenleaf Trust's biggest Q2 2026 reduction was Stryker, cutting an estimated $224M.
- Greenleaf Trust fully exited Liquidia Corp in Q2 2026, selling an estimated $529K.
- Greenleaf Trust's ten largest holdings make up 71% of its $10.4B portfolio in Q2 2026.
- Greenleaf Trust opened 106 new positions and closed 43 in Q2 2026.
- Greenleaf Trust's portfolio value rose 2.1% quarter-over-quarter to $10.4B.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.